Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. - Wikidata - awgldk - TriplyDB

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

http://www.wikidata.org/entity/Q37596048

about

Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.Relationship between white matter connectivity loss and cortical thinning in cerebral amyloid angiopathy.Emerging concepts in sporadic cerebral amyloid angiopathy.William M. Feinberg Award for Excellence in Clinical Stroke: Big Pictures and Small Vessels.Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.Measurement of cortical thickness asymmetry in carotid occlusive disease.Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.Evolution of DWI lesions in cerebral amyloid angiopathy: Evidence for ischemia.Cerebral amyloid angiopathy as a cause of neurodegeneration.Core CSF biomarker profile in cerebral amyloid angiopathy: A meta-analysis.Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.Updates on Prevention of Hemorrhagic and Lacunar Strokes.Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease

P2860

Q33700069-A5A626BC-9AA3-4D3A-B1BE-9E0C6C39D331 Q38636940-C58FCD4E-53C3-48CF-BF85-B0ACD81AB927 Q38688696-423C4BBB-D7BE-401B-AA2C-400E53833B01 Q39196370-35C39A2D-F766-400A-8AB1-97968E6DAF41 Q39429330-2A168D9E-4F9A-4592-81A3-AB463905B526 Q40361221-D2C56415-9A6C-4994-83E8-7395CB31E5F1 Q41320410-976591A7-2D5A-409A-8696-537DB288528F Q47117098-DA94B8A0-BBD2-495A-BFA2-D59B2E4289C7 Q48000789-35CEB9B6-27C7-41F9-B4C1-90266CB31049 Q48143369-73E9C918-8339-4DC8-9FA0-67A5D5256A41 Q49545848-E24BBE3E-8984-449C-BBCF-0B524D7FBBCE Q50043256-ACEE195F-C1E5-4783-8359-D154546F725C Q50591685-47A783E3-16FD-43A1-A9F9-75F9C57F1C6F Q54136792-36896CD6-8135-433E-A3AA-2652DE82C2C9 Q55400701-2A6529C2-6739-48CE-9F56-6FD3A15FCF65 Q57800439-B9389D88-3165-44DE-BE62-0F0DF4FCD33E

P2860

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

http://www.wikidata.org/entity/Q37596048

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@en

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@nl

type

label

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@en

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@nl

prefLabel

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@en

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@nl

P1433

Q37596048-358A7A9D-BE39-4273-A734-BBD0692A0479

P1476

Q37596048-73109E0B-5E47-4148-8501-DBA39CF010BD

P2093

Q37596048-17699A6A-3DBF-4282-99FF-F1DF9BD8BE78

Q37596048-23EF1D86-3C51-4E36-8535-5140A9DB3DB9

Q37596048-2CADDC76-8459-4285-9E9D-C967F2BC2B2F

Q37596048-4022561F-0F36-4063-877C-BC26FA0847F9

Q37596048-5909072C-3CA3-4724-9118-C3E6E659F3DF

Q37596048-5E658762-C792-40A3-8D9F-9C773CF18190

Q37596048-7DCDB7B2-AA76-439A-B868-FF2893F4440C

Q37596048-825627D1-961A-4814-B6B8-1BF36AB3435A

Q37596048-82B4BC84-D593-429F-91EA-3EBDBBD94BDF

Q37596048-85E6E472-CA88-4B50-911A-97D595CEABBB

P2860

Q37596048-0E4FE120-F82F-4755-8301-C65A3478698F

Q37596048-130EED6B-5C36-4B52-B103-8DC335112046

Q37596048-1811CDAB-395E-43DA-BE35-5766DBB61CCF

Q37596048-2060F8B5-F9B6-4D86-8E3D-7089BDC52112

Q37596048-22AEFAFE-3990-4ABB-AB0C-02C84D348652

Q37596048-33ADCDDD-FF13-497F-86E3-F7314A8212D1

Q37596048-342362C7-F594-40A6-BFC2-A5B667EA6962

Q37596048-407FECCA-9EF8-43E7-9018-E65328B5413B

Q37596048-41CBAACF-0CF8-4E26-AB29-7DAFE84AC481

Q37596048-422BBC55-C8AC-4A71-B1C0-580F50A2AD81

P304

Q37596048-7AD7F84C-5596-4CE7-A99E-7308F459F9FF

P31

Q37596048-40B4A21E-C797-43D2-B605-5CD6D7670931

P356

Q37596048-24973384-0B2B-43CD-88AA-BB25DC731644

P433

Q37596048-F09EC134-0A0E-479E-818F-0B2366252DCE

P478

Q37596048-72401B2F-AB85-4A5D-AE30-D175BB4E3B25

P50

Q37596048-0181146A-912E-4F87-9FFB-3359E2B31041

Q37596048-0455605B-5F08-44CF-85D7-4B12AC148EF0

Q37596048-5C76602D-C63E-425D-8B65-CB2FB3929E15

Q37596048-C17D62CE-7AFB-4EE4-B5FA-13E786202EDF

Q37596048-E914B555-829D-4F47-8DA5-FE5C6CF727F9

P577

Q37596048-3713FC76-BB7D-4C5A-AB2F-309A7997C00A

P698

Q37596048-AFD19061-8B40-4861-B3F7-D6BC27CDA888

P932

Q37596048-D9C33922-044C-4FF6-973C-D36807EBE3E7

P356

S1474-4422(16)30030-8

P1433

Lancet Neurology

P1476

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

@en

P2093

Alison Ayres

http://www.w3.org/2001/XMLSchema#string

Anand Viswanathan

http://www.w3.org/2001/XMLSchema#string

Anna M van Opstal

http://www.w3.org/2001/XMLSchema#string

Eitan Auriel

http://www.w3.org/2001/XMLSchema#string

Jeroen van der Grond

http://www.w3.org/2001/XMLSchema#string

Keith A Johnson

http://www.w3.org/2001/XMLSchema#string

Kristin M Schwab

http://www.w3.org/2001/XMLSchema#string

M Edip Gurol

http://www.w3.org/2001/XMLSchema#string

Marieke Wermer

http://www.w3.org/2001/XMLSchema#string

Mark A van Buchem

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer mechanisms and therapeutic strategies

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

Neuropathological alterations in Alzheimer disease

Cortical Surface-Based Analysis

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

Measuring the thickness of the human cerebral cortex from magnetic resonance images

Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment.

P304

811-819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(16)30030-8

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Rosand

Alzheimer's Disease Neuroimaging Initiative

Jonathan R Polimeni

Aaron P. Schultz

Gisela M Terwindt

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27180034

http://www.w3.org/2001/XMLSchema#string

P932

5248657

http://www.w3.org/2001/XMLSchema#string